Kenvue Inc. (NYSE:KVUE) Shares Bought by Mather Group LLC.

Mather Group LLC. grew its position in Kenvue Inc. (NYSE:KVUE) by 29.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,766 shares of the company’s stock after purchasing an additional 3,139 shares during the period. Mather Group LLC.’s holdings in Kenvue were worth $330,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. SRS Capital Advisors Inc. raised its holdings in shares of Kenvue by 67.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock worth $30,000 after purchasing an additional 571 shares during the last quarter. Clarity Asset Management Inc. acquired a new stake in Kenvue during the 4th quarter worth about $45,000. SBI Securities Co. Ltd. purchased a new position in shares of Kenvue during the 4th quarter valued at about $46,000. Continuum Advisory LLC lifted its holdings in shares of Kenvue by 2,071.1% in the 1st quarter. Continuum Advisory LLC now owns 1,954 shares of the company’s stock valued at $47,000 after buying an additional 1,864 shares during the period. Finally, Golden State Wealth Management LLC boosted its stake in shares of Kenvue by 292.0% in the first quarter. Golden State Wealth Management LLC now owns 3,081 shares of the company’s stock worth $74,000 after buying an additional 2,295 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on KVUE. Barclays lifted their price target on Kenvue from $22.00 to $23.00 and gave the company an “equal weight” rating in a research report on Monday, May 12th. Evercore ISI started coverage on shares of Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price for the company. Citigroup reissued a “neutral” rating on shares of Kenvue in a report on Friday, June 13th. UBS Group lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a report on Friday, May 9th. Finally, Redburn Atlantic assumed coverage on shares of Kenvue in a research report on Thursday, April 10th. They issued a “neutral” rating and a $23.50 price objective for the company. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $25.33.

Kenvue Trading Up 0.6%

Shares of Kenvue stock opened at $21.02 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.60 and a debt-to-equity ratio of 0.63. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.17. The firm has a market capitalization of $40.32 billion, a PE ratio of 38.21, a P/E/G ratio of 3.25 and a beta of 0.83. The firm’s 50-day moving average price is $22.69 and its 200 day moving average price is $22.33.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion for the quarter, compared to the consensus estimate of $3.69 billion. During the same quarter last year, the business posted $0.28 earnings per share. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. On average, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue’s payout ratio is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.